Abstract:Dengue virus infection is a major cause of morbidity within the endemic tropical and subtropical regions of the world. Dengue virus has four distinct serotypes with specific clinical manifestations. In this study, we observed the changing pattern of dengue serotypes, age-wise dengue infection and useful sero-detection methods needed in a dengue endemic region. We identified dengue serotypes during a period of 5 years among patients with dengue symptoms visiting one of the largest tertiary care infectious disea… Show more
“…According to previous articles, 48 to 2012. 50 In Puerto Rico, 87.0% of the reported cases were identified during 2012 to 2013, the DENV-1 was dominant in that period. 26 These findings suggest that the dominance of dengue virus serotypes in India and Puerto Rico may be associated with the clear difference of the reported cases between DENV-1 and DENV-2 identified in this systematic review and meta-analysis.…”
Section: Discussionmentioning
confidence: 99%
“…The dominant prevalence of DENV‐1 was shown in two countries with the largest number of cases India and Puerto Rico compared with DENV‐2. In India, 77.8% of the reported cases were confirmed during 2011 to 2012, the DENV‐1 was dominant followed by DENV‐3 during 2008 to 2012 . In Puerto Rico, 87.0% of the reported cases were identified during 2012 to 2013, the DENV‐1 was dominant in that period .…”
We systematically searched and meta-analyzed the epidemiological characteristics, frequency of clinical signs, and outcomes of dengue-associated hemophagocytic lymphohistiocytosis. Ten electronic databases were searched systematically plus manual search of reference lists to identify relevant articles published until May 2017. The highest number of reported cases were from South-East Asia region (62 cases), followed by Western Pacific region (20 cases), and America (31 cases). The term "dengue hemorrhagic fever" predominated in studies that used the World Health Organization 1997 definition (59.7%), whereas "severe dengue" predominated in studies using the World Health Organization 2009 definition (76.8%). Among 122 cases, fever, splenomegaly, hepatomegaly, anemia, thrombocytopenia, and serum ferritin ≥500 μg/L were likely to report by articles representing by large sample size. The pooled proportion of these findings were as follows: fever 97.2%, hepatomegaly 70.2%, splenomegaly 78.4%, thrombocytopenia 90.1%, anemia 76.0%, and serum ferritin ≥500 μg/L 97.1%. This study highlighted a high case fatality rate (14.6%) and co-infection among dengue hemophagocytic lymphohistiocytosis patients. We suggest that long fever duration, persistent thrombocytopenia, elevated serum ferritin, and lactate dehydrogenase levels could be good diagnostic indicators for dengue-associated hemophagocytic syndrome. Bone marrow aspiration could be used as one criterion for diagnosis but is not obligatory. Further research is needed to examine the possible risk difference for development of hemophagocytic syndrome and to explore potential relationships between specific dengue classifications and dengue-associated hemophagocytic syndrome.
“…According to previous articles, 48 to 2012. 50 In Puerto Rico, 87.0% of the reported cases were identified during 2012 to 2013, the DENV-1 was dominant in that period. 26 These findings suggest that the dominance of dengue virus serotypes in India and Puerto Rico may be associated with the clear difference of the reported cases between DENV-1 and DENV-2 identified in this systematic review and meta-analysis.…”
Section: Discussionmentioning
confidence: 99%
“…The dominant prevalence of DENV‐1 was shown in two countries with the largest number of cases India and Puerto Rico compared with DENV‐2. In India, 77.8% of the reported cases were confirmed during 2011 to 2012, the DENV‐1 was dominant followed by DENV‐3 during 2008 to 2012 . In Puerto Rico, 87.0% of the reported cases were identified during 2012 to 2013, the DENV‐1 was dominant in that period .…”
We systematically searched and meta-analyzed the epidemiological characteristics, frequency of clinical signs, and outcomes of dengue-associated hemophagocytic lymphohistiocytosis. Ten electronic databases were searched systematically plus manual search of reference lists to identify relevant articles published until May 2017. The highest number of reported cases were from South-East Asia region (62 cases), followed by Western Pacific region (20 cases), and America (31 cases). The term "dengue hemorrhagic fever" predominated in studies that used the World Health Organization 1997 definition (59.7%), whereas "severe dengue" predominated in studies using the World Health Organization 2009 definition (76.8%). Among 122 cases, fever, splenomegaly, hepatomegaly, anemia, thrombocytopenia, and serum ferritin ≥500 μg/L were likely to report by articles representing by large sample size. The pooled proportion of these findings were as follows: fever 97.2%, hepatomegaly 70.2%, splenomegaly 78.4%, thrombocytopenia 90.1%, anemia 76.0%, and serum ferritin ≥500 μg/L 97.1%. This study highlighted a high case fatality rate (14.6%) and co-infection among dengue hemophagocytic lymphohistiocytosis patients. We suggest that long fever duration, persistent thrombocytopenia, elevated serum ferritin, and lactate dehydrogenase levels could be good diagnostic indicators for dengue-associated hemophagocytic syndrome. Bone marrow aspiration could be used as one criterion for diagnosis but is not obligatory. Further research is needed to examine the possible risk difference for development of hemophagocytic syndrome and to explore potential relationships between specific dengue classifications and dengue-associated hemophagocytic syndrome.
“…Over the past two decades, India has experienced a dramatic increase in the frequency of dengue cases. More precisely, in states like Kerala, Delhi, and West Bengal, the situation has worsened after the Dengue‐3 serotype introduction . As per the 2016 WHO guideline, the clinical manifestation of dengue fever varies from a nonspecific febrile illness to vomiting and fluid accumulation.…”
Section: Introductionmentioning
confidence: 99%
“…Delhi, and West Bengal, the situation has worsened after the Dengue-3 serotype introduction. 4 As per the 2016 WHO guideline, the clinical manifestation of dengue fever varies from a nonspecific febrile illness to vomiting and fluid accumulation. Restless state, lethargy, and rapid decline in the number of platelets were classified in dengue with warning signs (DWWS), while vasodilatation and fluid accumulation in the lung with respiratory difficulty and continuous bleeding was classified in severe dengue (SD).…”
Dengue is the most common arboviral infection globally, but its pathogenesis is poorly explored. Vascular endothelial growth factor (VEGF) has an essential role in the host defense against viral infection. However, not much information is available regarding its status in dengue patients from the eastern zone of India. In the present investigation, the level of VEGF was investigated for its possible utility as a dengue severity marker. Accordingly, confirmed dengue cases were enrolled during 2016‐2018. Serum from all the study subjects was subjected to the standard enzyme‐linked immunosorbent assay test for VEGF analysis. In addition, we assessed the association of VEGF to dengue severity. The study revealed that VEGF titers (P < .0001) were significantly increased in severe dengue (SD) patients in contrast to those with a milder form of dengue. An association was obtained between VEGF and increased SGOT (r = 0.517 with P < .0001) while VEGF had a negative correlation with platelets in SD patients (r = −0.331 with P = .001). Enhanced VEGF titers along with decreased platelets had a good association with SD. The investigation revealed that high VEGF titers are novel indicators of dengue severity. However, our results must be verified in a study evaluating a larger number of dengue patients.
“…Numerous studies have already described the relationship between DENV serotypes, genotypes and/or lineages, and clinical outcome severity as well as their epidemic potential. Research was conducted in multiple areas to study shifts in serotype and lineage or clade of circulating dengue virus which caused more severe dengue epidemics . A study by Watt et al linked American genotype of DENV2 with less severe infections.…”
Dengue viral infection has become a challenge in tropical and subtropical countries where dengue virus is endemic. Its epidemics are occurring at higher rates amid its circulation throughout the year. Since the first documented outbreak in Pakistan in 1994, this region has reported many sporadic cases and epidemics. There is availability of small scale demographic and epidemiological studies on dengue viral infection in Pakistan. The year 2017 witnessed a huge dengue outbreak in Peshawar city of Pakistan with 69 deaths and 24 807 laboratory-confirmed cases. We suspect that the circulation of a different lineage or genotype could be responsible for the enhanced number of infected patients in Pakistanʼs 2017 outbreak since previous studies have already described this phenomenon in other countries. For this, we collected 1447 suspected blood samples and their epidemiological data. After serotyping through polymerase chain reaction nine samples of Dengue virus2 (DENV2) were randomly selected and were subjected to Sangerʼs sequencing for genotyping analysis. The mean distance, genetic diversity, and phylogenetic analysis were carried out using K2 model. The phylogenetic analysis split Pakistani isolates into two lineages, the sequences from 2017 outbreak in Peshawar grouped within A1 lineage of cosmopolitan genotype (IV) of DENV2. The difference in distance, genetic diversity, and amino acids composition strongly back the results that the new lineage is circulating in the region. This is significant as Pakistan is struggling to control dengue epidemics which have caused much loss in both monetary and health sectors. K E Y W O R D S dengue, new lineage, outbreak, Pakistan, serotype 2 | 1915
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.